Creative Planning - GALECTIN THERAPEUTICS INC ownership

GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 66 filers reported holding GALECTIN THERAPEUTICS INC in Q2 2014. The put-call ratio across all filers is 2.09 and the average weighting 0.1%.

Quarter-by-quarter ownership
Creative Planning ownership history of GALECTIN THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$38,811
+28.1%
20,214
-4.0%
0.00%
Q2 2023$30,309
-31.4%
21,0480.0%0.00%
Q1 2023$44,201
+85.8%
21,0480.0%0.00%
Q4 2022$23,784
-30.0%
21,0480.0%0.00%
Q3 2022$34,000
+21.4%
21,0480.0%0.00%
Q2 2022$28,000
-17.6%
21,0480.0%0.00%
Q1 2022$34,000
+47.8%
21,048
+90.5%
0.00%
Q4 2021$23,000
+666.7%
11,048
+860.7%
0.00%
Q2 2017$3,0001,150
+666.7%
0.00%
Q1 2017$0150
-69.3%
0.00%
Q4 2016$0488
+225.3%
0.00%
Q3 2016$01500.0%0.00%
Q2 2016$01500.0%0.00%
Q1 2016$01500.0%0.00%
Q4 2015$0
-100.0%
150
-98.1%
0.00%
Q3 2015$18,000
-30.8%
7,8170.0%0.00%
Q1 2015$26,000
-3.7%
7,817
+2.0%
0.00%
Q4 2014$27,000
-30.8%
7,6670.0%0.00%
Q3 2014$39,000
-63.2%
7,6670.0%0.00%
-100.0%
Q2 2014$106,000
-9.4%
7,6670.0%0.00%
-50.0%
Q1 2014$117,000
+88.7%
7,6670.0%0.00%
+100.0%
Q4 2013$62,000
-18.4%
7,6670.0%0.00%
-50.0%
Q3 2013$76,000
+130.3%
7,6670.0%0.00%
+100.0%
Q2 2013$33,0007,6670.00%
Other shareholders
GALECTIN THERAPEUTICS INC shareholders Q2 2014
NameSharesValueWeighting ↓
Cutter & CO Brokerage, Inc. 184,742$401,0000.10%
Geneos Wealth Management Inc. 511,606$2,261,0000.06%
SHEPHERD KAPLAN KROCHUK, LLC 12,000$26,0000.01%
OCCUDO QUANTITATIVE STRATEGIES LP 18,967$41,0000.01%
Vivaldi Capital Management LP 10,668$45,0000.01%
OSAIC HOLDINGS, INC. 1,221,984$2,651,0000.01%
CENTAURUS FINANCIAL, INC. 15,614$34,0000.00%
WEDBUSH SECURITIES INC 17,998$39,0000.00%
D.A. DAVIDSON & CO. 65,310$142,0000.00%
Virtu Financial LLC 14,683$32,0000.00%
View complete list of GALECTIN THERAPEUTICS INC shareholders